The RANK/RANKL/OPG system has recently been recognised as the ultimate mediator of osteoclastogenesis30, 35, and the dysregulation of the OPG–RANKL system is thought to be crucial to the bone disease connected with cancers such as prostate cancer36. Here, TNFRSF11A is linked to cancer.